Supernus Pharmaceuticals (SUPN)

MDD US Enterprises, LLC • MDD US Operations, LLC • Supernus Europe Ltd. • Adamas Pharmaceuticals, LLC • Adamas Operations, LLC • Adamas Holdings, LLC • Biscayne Neurotherapeutics, Inc. ...

SUPN stock data

1M 3M 6M 1Y

Latest filings (excl ownership)

View all

8-K

Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics

4 Nov 24

Supernus Announces Third Quarter 2024 Financial Results

4 Nov 24

8-K

Regulation FD Disclosure

30 Oct 24

8-K

Results of Operations and Financial Condition

21 Oct 24

8-K

Supernus Announces Promising Data from Open-Label Phase 2a Study of SPN-820 in Adults with Major Depressive Disorder

17 Oct 24

8-K

Supernus Pharmaceuticals to Host Webcast to Review Open-Label Phase 2a Study of SPN-820 for the Treatment of Major Depressive Disorder

10 Oct 24

8-K

Supernus Announces SPN-830 Apomorphine Infusion Device NDA Accepted for Review by FDA

Supernus Pharmaceuticals to Announce Second Quarter 2024 Financial

23 Jul 24

Transcripts

View all

SUPN

Earnings call transcript

2024 Q3

4 Nov 24

SUPN

Earnings call transcript

2024 Q2

6 Aug 24

SUPN

Earnings call transcript

2024 Q1

8 May 24

SUPN

Earnings call transcript

2023 Q4

27 Feb 24

SUPN

Earnings call transcript

2023 Q3

8 Nov 23

SUPN

Earnings call transcript

2023 Q2

8 Aug 23

SUPN

Earnings call transcript

2023 Q2

8 Aug 23

SUPN

Earnings call transcript

2023 Q1

9 May 23

SUPN

Earnings call transcript

2022 Q4

28 Feb 23

SUPN

Earnings call transcript

2022 Q3

8 Nov 22

Latest ownership filings

View all

Padmanabh P. Bhatt

4 Dec 24

144

Notice of proposed sale of securities

3 Dec 24

SC 13G/A

ARMISTICE CAPITAL, LLC

14 Nov 24

CHARLES W NEWHALL III

Notice of proposed sale of securities

12 Nov 24

144

Notice of proposed sale of securities

8 Nov 24

144

Notice of proposed sale of securities

8 Nov 24

Financial summary

Financial statements Chart SUPN financial data

Quarter (USD)	Sep 24	Dec 23	Sep 23	Jun 23
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 23	Dec 22	Dec 21	Dec 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	31.67 mm	31.67 mm	31.67 mm	31.67 mm	31.67 mm	31.67 mm
Cash burn (monthly)	14.46 mm	35.88 mm	(no burn)	(no burn)	(no burn)	(no burn)
Cash used (since last report)	40.48 mm	100.45 mm	n/a	n/a	n/a	n/a
Cash remaining	-8.81 mm	-68.77 mm	n/a	n/a	n/a	n/a
Runway (months of cash)	-0.6	-1.9	n/a	n/a	n/a	n/a

Beta Read what these cash burn values mean

Financial data from company earnings reports.

Institutional ownership, Q2 2024

SUPN institutional ownership history Ownership history

13F holders	Current	Prev Q	Change
Total holders	241	222	+8.6%
Opened positions	50	60	-16.7%
Closed positions	31	35	-11.4%
Increased positions	75	50	+50.0%
Reduced positions	74	70	+5.7%

13F shares	Current	Prev Q	Change
Total value	1.46 tn	1.65 tn	-11.6%
Total shares	58.36 mm	54.09 mm	+7.9%
Total puts	13.10 k	51.70 k	-74.7%
Total calls	47.90 k	75.80 k	-36.8%
Total put/call ratio	0.3	0.7	-59.9%

Largest owners	Shares	Value	Change
BLK BlackRock	10.39 mm	$278.00 bn	+0.3%
Vanguard	6.14 mm	$164.18 bn	-1.1%
Armistice Capital	5.27 mm	$141.03 bn	+47.6%
Dimensional Fund Advisors	2.87 mm	$76.69 bn	+12.1%
MQBKY Macquarie Group Limited	2.68 mm	$71.69 bn	+0.4%
STT State Street	2.16 mm	$57.88 bn	+6.1%
Polar Capital	1.94 mm	$51.91 bn	0.0%
Stephens Investment Management	1.90 mm	$50.78 bn	-0.2%
Renaissance Technologies	1.69 mm	$45.08 bn	+26.4%
Loomis Sayles & Co L P	1.56 mm	$41.63 mm	-2.6%

Largest transactions	Shares	Bought/sold	Change
Armistice Capital	5.27 mm	+1.70 mm	+47.6%
Pacer Advisors	1.35 mm	+1.35 mm	+100186.3%
Woodline Partners	0.00	-1.29 mm	EXIT
Congress Asset Management	9.08 k	-1.02 mm	-99.1%
Ashford Capital Management	711.89 k	+711.89 k	NEW
Charles Schwab Investment Management	621.04 k	+621.04 k	NEW
Pictet Asset Management Holding	545.90 k	-444.14 k	-44.9%
BAC Bank of America	405.60 k	+405.60 k	NEW
T. Rowe Price	47.52 k	-395.23 k	-89.3%
American Century Companies	501.66 k	+394.73 k	+369.1%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

SUPN insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
3 Dec 24	Padmanabh P. Bhatt	Common Stock	Sell	Dispose S	No	No	36.68	12,745	467.49 k	9,679
3 Dec 24	Padmanabh P. Bhatt	Common Stock	Option exercise	Acquire M	No	No	25.3	12,745	322.45 k	22,424
3 Dec 24	Padmanabh P. Bhatt	Common Stock	Sell	Dispose S	No	No	36.68	8,750	320.95 k	9,679
3 Dec 24	Padmanabh P. Bhatt	Common Stock	Option exercise	Acquire M	No	No	23.99	8,750	209.91 k	18,429
3 Dec 24	Padmanabh P. Bhatt	Employee Stock Option Common Stock	Option exercise	Dispose M	No	No	25.3	12,745	322.45 k	0
3 Dec 24	Padmanabh P. Bhatt	Employee Stock Option Common Stock	Option exercise	Dispose M	No	No	23.99	8,750	209.91 k	0
11 Nov 24	Charles W Newhall Iii	Common Stock	Sell	Dispose S	No	No	36.24	10,700	387.77 k	130,275
11 Nov 24	Charles W Newhall Iii	Common Stock	Option exercise	Acquire M	No	No	9.13	20,000	182.60 k	140,975
11 Nov 24	Charles W Newhall Iii	Director Stock Option Common Stock	Option exercise	Dispose M	No	No	9.13	20,000	182.60 k	0
8 Nov 24	Hudson Frederick M.	Common Stock	Sell	Dispose S	No	No	36.28	8,722	316.43 k	28,395